Anesthesia during cardiologic procedures

Current Opinion in Anaesthesiology

Volumn 22, Issue 4, 2009, Pages 519-523

  Haas, Sebastian ^a   Richter, Hans Peter ^a   Kubitz, Jens C ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Cardiac catheterization laboratory; Cardiologic procedures; Offsite anesthesia

Indexed keywords

ADRENALIN; ANESTHETIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE; DOBUTAMINE; ETOMIDATE; FENTANYL; HEPARIN; INHALATION ANESTHETIC AGENT; LEAD; LEVOSIMENDAN; LOCAL ANESTHETIC AGENT; MIDAZOLAM; MILRINONE; NALBUPHINE; OPIATE; PROPOFOL;

ACUTE HEART INFARCTION; AGING; ANALGESIA; ANESTHESIA; ANESTHESIA INDUCTION; ANESTHESIST; ANTICOAGULATION; AORTA VALVE REGURGITATION; ARTIFICIAL HEART PACEMAKER; ARTIFICIAL VENTILATION; CARDIOGENIC SHOCK; CARDIOPULMONARY BYPASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CATHETER ABLATION; CEREBROVASCULAR DISEASE; CHANNELOPATHY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; DEFIBRILLATOR; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FLUID THERAPY; HEART ARRHYTHMIA; HEART CATHETERIZATION; HEART ELECTROPHYSIOLOGY; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART PACING; HEART PROTECTION; HEART VENTRICLE PERFORATION; HEMODYNAMICS; HIGH RISK POPULATION; HUMAN; KIDNEY FAILURE; LABORATORY TEST; MITRAL VALVE REGURGITATION; PAIN; PERCUTANEOUS CORONARY INTERVENTION; PNEUMOTHORAX; POSITIVE END EXPIRATORY PRESSURE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SEDATION; TRANSLUMINAL CORONARY ANGIOPLASTY; TRANSLUMINAL VALVULOPLASTY; TRICUSPID VALVE DISEASE; TRICUSPID VALVE REGURGITATION; VALVULAR HEART DISEASE;

ANESTHESIA; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIAC PACING, ARTIFICIAL; CARDIAC SURGICAL PROCEDURES; DEFIBRILLATORS; HEART VALVE DISEASES; HUMANS;

EID: 68949116124     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e32832dbad6     Document Type: Review

References (32)

1. Shook DC, Gross W. Offsite anesthesiology in the cardiac catheterization lab. Curr Opin Anaesthesiol 2007; 20:352-358.
2. Frank SM, Beattie C, Christopherson R, et al. Unintentional hypothermia is associated with postoperative myocardial ischemia. The Perioperative Ischemia Randomized Anesthesia Trial Study Group. Anesthesiology 1993; 78:468-476.
3. Frank SM, Fleisher LA, Breslow MJ, et al. Perioperative maintenance of normothermia reduces the incidence of morbid cardiac events. A randomized clinical trial. JAMA 1997; 277:1127-1134.
4. Leslie K, Sessler DI. Perioperative hypothermia in the high-risk surgical patient. Best Pract Res Clin Anaesthesiol 2003; 17:485-498.
5. Weber NC, Schlack W. Inhalational anaesthetics and cardioprotection. Handb Exp Pharmacol 2008; 182:187-207.
6. De Hert SG. Cardioprotection with volatile anesthetics: clinical relevance. Curr Opin Anaesthesiol 2004; 17:57-62.
7. Larsen JR, Aagaard S, Lie RH, et al. Sevoflurane improves myocardial ischaemic tolerance in a closed-chest porcine model. Acta Anaesthesiol Scand 2008; 52:1400-1410.
8. Bienengraeber MW, Weihrauch D, Kersten JR, et al. Cardioprotection by volatile anesthetics. Vasc Pharmacol 2005; 42 (5-6):243-252.
9. Pratt PF Jr, Wang C, Weihrauch D, et al. Cardioprotection by volatile anesthetics: new applications for old drugs? Curr Opin Anaesthesiol 2006; 19:397-403.
10. Reddy K, Jaggar S, Gillbe C. The anaesthetist and the cardiac catheterisation laboratory. Anaesthesia 2006; 61:1175-1186.
11. Moss AJ, Zareba W, Hall WJ, et al. Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346:877-883.
12. Bardy GH, Lee KL, Mark DB, etal. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defi-brillator for congestive heart failure. N Engl J Med 2005; 352:225-237.
13. Riera AR, Zhang L, Uchida AH, et al. The management of Brugada syndrome patients. Cardiol J 2007; 14:97-106.
14. Stix G, Anvari A, Podesser B, et al. Local anaesthesia versus general anaesthesia for cardioverter-defibrillator implantation. Wien Klin Wochenschr 1999; 111:406-409.
15. Marquie C, Duchemin A, Klug D, etal. Can we implant cardioverter defibrillator under minimal sedation? Europace 2007; 9:545-550.
16. Zeymer U, Zahn R, Hochadel M, etal. Indications and complications of invasive diagnostic procedures and percutaneous coronary interventions in the year 2003. Results of the quality control registry of the ArbeitsgemeinschaftLeitender Kardiologischer Krankenhausärzte (ALKK). Z Kardiol 2005; 94:392-398.
17. Goldberg RJ, Samad NA, Yarzebski J, et al. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 1999; 340:1162-1168.
18. Page DL, Korfield JB, Kator JA, et al. Myocardial changes associated with cardiogenic shock. N Engl J Med 1971; 285:133-137.
19. Alonso BR, Scheid S, Post M, et al. Pathophysiology of cardiogenic shock: quantitation of myocardial necrosis, clinical pathological and electrocardio-graphic correlations. Circulation 1973; 48:588-596.
20. Greif M, Zwermann L, Reithmann C, Weis M. Levosimendan as rescue therapy in severe cardiogenic shock after ST-elevation myocardial infarction. Acute Card Care 2008; 10:185-190.
21. Fuhrmann JT, Schmeisser A, Schulze MR, et al. Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction. Crit Care Med 2008; 36:2257-2266.
22. Ohman EM, George BS, White CJ, et al. Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The Randomized IABP Study Group. Circulation 1994; 90:792-799.
23. Kar B, Adkins LE, Civitello AB 3rd, et al. Clinical experience with the TandemHeart percutaneous ventricular assist device. Tex Heart Inst J 2006; 33:111-115.
24. American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons, Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006; 114:e84-e231.
25. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogen-esis, disease progression, and treatment strategies. Circulation 2005; 111:3316-3326.
26. Brown JM, O'Brien SM, Wu C, et al. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg 2009; 137:82-90.
27. Tamburino C, Capodanno D, Mul EM, et al. Procedural success and 30-day clinical outcomes after percutaneous aortic valve replacement using current third-generation self-expanding CoreValve prosthesis. J Invasive Cardiol 2009; 21:93-98.
28. Rodés-Cabau J, Dumont E, De LaRochellière R, et al. Feasibility and initial results of percutaneous aortic valve implantation including selection of the transfemoral or transapical approach in patients with severe aortic stenosis. Am J Cardiol 2008; 102:1240-1246.
29. Singh IM, Shishehbor MH, Christofferson RD, et al. Percutaneous treatment of aortic valve stenosis. Cleve Clin J Med 2008; 75:805-812.
30. Inoue K, Owaki T, Nakamura T, et al. Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg 1984; 87:394-402.
31. Palacios I, Block PC, Brandi S, et al. Percutaneous balloon valvotomy for patients with severe mitral stenosis. Circulation 1987; 75:778-784.
32. Feldman T, Wasserman HS, Herrmann HC, et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol 2005; 46:2134-2140.